
Teva’s CEO shares ‘Pivot to Growth’ progress
The Top Line
00:00
Navigating Generics and Biosimilars
This chapter discusses a company's dedication to its generics and biosimilars, highlighting the challenges of adoption in the US market. It also covers strategic shifts aimed at reducing reliance on US sales and focusing on international expansion and innovative products for long-term growth.
Transcript
Play full episode